Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 22, 16:00
2456.65
-29.8 (-1.2%)
VOLUME 137,301
LIVE
NSE
Sep 22, 15:54
2457.75
-28.8 (-1.16%)
VOLUME 1,991,351
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Pharma stocks extend gains, Divis & Dr Reddy's get reprieve from US FDA

5.36 pm | 23 Sep 2017 |  Source: Moneycontrol.com

Pharma stocks extended their gain this week on the back of sustained investor interest in the sector owing to attractive valuations....

Regulatory issues should reduce going ahead for DRL: Edelweiss Sec 

2.20 pm | 22 Sep 2017 |  Source: CNBC-TV18

Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happe...

Buy Dr Reddys Laboratories; target of Rs 3500: Edelweiss

11.42 am | 22 Sep 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Dr Reddys Laboratories has recommended buy rating on the stock with a target price of Rs 3500 in its research report dated Sep...

Dr Reddy's gets EIR for 2 facilities

1.47 pm | 21 Sep 2017 |  Source: PTI

The company has received EIR from the United States Food and Drug Administration (USFDA) for its formulations manufacturing facility at Srikakulam uni...

Positive sentiment for pharma stocks lifts Cipla 4%; UBS maintains buy

1.46 pm | 21 Sep 2017 |  Source: Moneycontrol.com

"Cipla is our top pick in the sector given high branded generic exposure," UBS said....

Top buzzing midcap stocks to trade on September 21 

1.06 pm | 21 Sep 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Dr Reddys, NBCC, Divis Laboratories, Dishman Pharma, Las...

Dr Reddy’s Laboratories receives EIR from USFDA

10.53 am | 21 Sep 2017 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories has received an establishment inspection report (EIR) from the US Food and Drug Administration, for Formulation Srikakulam P...

Upbeat CLSA view, procedural observations from US FDA send DRL stock up 3%

12.38 pm | 20 Sep 2017 |  Source: Moneycontrol.com

The global broking firm also observed that three products, Nuvaring, Suboxone & Copaxone will be major contributors over FY19-20. In fact, the EPS for...

Buy, Sell, Hold: 4 sectors and 2 sectors are on analysts’ radar today

9.06 am | 14 Sep 2017 |  Source: CNBC-TV18

Sun Pharma, Jubilant Foodworks and OMCs are being tracked by investors on Thursday....

Dr Reddy's Laboratories up 2% on phase-2 trial of CA-170

10.53 am | 13 Sep 2017 |  Source: Moneycontrol.com

The company's wholly owned subsidiary Aurigene Discovery Technologies is planning to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to...

DRL's arm Aurigene plans phase II trials for CA-170 in India

9.04 am | 13 Sep 2017 |  Source: PTI

Commenting on the development, Aurigene CEO CSN Murthy said: "Together with Curis, we have designed a phase II trial in selected populations of patien...

Stocks in the news: Dr Reddy's Lab, Tata Chemicals, Infosys, Lupin, Tata Motors 

8.18 am | 13 Sep 2017 |  Source: CNBC-TV18

Dr Reddy’s Laboratories | ONGC | Oil India | Tata Chemicals | Infosys | Lupin and Tata Motors are stocks which are in news today....

Pharma wrap: Dr Reddy's German observation, Cadila clearing US inspection & more

2.12 pm | 09 Sep 2017 |  Source: Moneycontrol.com

The sector was kept busy with Dr Reddy's German regulator observations, Cadila Healthcare clearing US FDA inspection with zero observations, Bioco...

Timeline of Dr Reddy's regulatory issues and stock price movement

2.01 pm | 08 Sep 2017 |  Source: Moneycontrol.com

The latest jab is a part of the never-ending saga of regulatory compliance woes the company has been facing starting November 2015...

Dr Reddy's Vizag unit gets 6 observations by German regulator

12.25 pm | 08 Sep 2017 |  Source: PTI

"The Regulatory Authority of Germany (Regierung von Oberbayern) concluded an audit of our formulations facility in Duvvada, Visakhapatnam with zero cr...

Top buzzing stocks to trade on September 8 

12.24 pm | 08 Sep 2017 |  Source: CNBC-TV18

Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today – Dr Reddy’s Laboratories (DRL), Future Enterprises, Vista Pha...

German regulator issues 6 major observations to Dr Reddy's Duvvada facility, shares down 

11.32 am | 08 Sep 2017 |  Source: Moneycontrol.com

The auditor has cautioned that the facility will receive EU-GMP certification for the regulator up to November 2018 only when the regulator approves C...

Dr Reddy's plunges 7% on 6 major observations from German regulator for Duvvada unit

11.17 am | 08 Sep 2017 |  Source: Moneycontrol.com

Regulatory Authority of Germany concluded an audit of formulations manufacturing facility in Duvvada, Vishakapatnam, with zero critical and six major ...

Dr Reddy's likely to divest Penicillin assets in US: Sources 

1.36 pm | 06 Sep 2017 |  Source: CNBC-TV18

The drug maker, besieged by pricing pressures and regulatory problems at its facilities, is looking to sell its oral penicillin manufacturing site in ...

This week in pharma: Lupin, Cadila, Strides Shasun get clearances from US FDA

2.28 pm | 02 Sep 2017 |  Source: Moneycontrol.com

The BSE Healthcare index gained 0.96 percent in the past week, the benchmark Sensex rose 0.43 percent....

1 2 3
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.